Large Molecule Bioanalysis done differently

To help you achieve more.

We are a bioanalytical lab that has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

biomarkers

Biomarkers

immunogenicity

Immunogenicity

pharmacokinetics

Pharmacokinetics (PK)

cell-based-assays

Cell-Based Assays

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.

biosimilars

Biosimilars

gene-therapy

Gene Therapy

antibody-drug-conjugates

Antibody Drug Conjugates (ADCs)

immuno-oncology

Immuno-oncology

platform comparison guide

webinar title
NOW ACCESSIBLE ON-DEMAND

Clinical Relevance of (Unwanted Drug-Induced) Immune Responses

Webinar Co-Hosted with Bioanalysis Zone

Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant? BioAgilytix’s Global CSO, Dr. Arno Kromminga addresses this subject and more.

Download Recording

The Bioagilytix Perspective

Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.

resource center

Visit Resource Center

usa europe labs

Advanced bioanalytical lab facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • 4 Days Agoview on linkedin

    BioAgilytix

    Join Dr. Arno Kromminga and Dr. Lydia Michaut on 14 May at 15:00 CEST for their webinar, “Immunogenicity assessment of gene therapy compounds: discussion on current and future concepts”. Register with Bioanalysis Zone to hold your spot today! https://lnkd.in/ee5QWZ8

  • 4 Days Agoview on linkedin

    BioAgilytix

    BioAgilytix’s President & CEO, Jim Datin, recently discussed how BioAgilytix is supporting the exciting trends and projected growth in large molecule development. Visit our resource center to hear the full podcast or read the transcript: https://lnkd.in/euG6t2Z

  • 5 Days Agoview on linkedin

    BioAgilytix

    Flow cytometry is an ideal platform for many applications involving the study of complex cell populations. In the first blog of our new “The Fit for Flow” series, we discuss what makes flow cytometry the platform of choice for receptor occupancy (RO) studies: https://lnkd.in/eQTQaMx

global map

Advancing Bioanalytical Excellence Internationally

Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.